Analyzing SANUWAVE Health (OTCMKTS:SNWV) and Biotricity (NASDAQ:BTCY)

Profitability

This table compares SANUWAVE Health and Biotricity’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
SANUWAVE Health	-1.33%	-23.83%	-20.60%
Biotricity	-80.42%	N/A	-188.47%

Valuation & Earnings

This table compares SANUWAVE Health and Biotricity”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
SANUWAVE Health	$41.28 million	6.44	-$25.81 million	($1.30)	-23.83
Biotricity	$12.06 million	0.72	-$14.09 million	($0.17)	-1.83

Biotricity has lower revenue, but higher earnings than SANUWAVE Health. SANUWAVE Health is trading at a lower price-to-earnings ratio than Biotricity, indicating that it is currently the more affordable of the two stocks.

Volatility & Risk

SANUWAVE Health has a beta of 1.34, meaning that its stock price is 34% more volatile than the S&P 500. Comparatively, Biotricity has a beta of 1.4, meaning that its stock price is 40% more volatile than the S&P 500.

Insider and Institutional Ownership

42.5% of SANUWAVE Health shares are held by institutional investors. Comparatively, 3.9% of Biotricity shares are held by institutional investors. 14.9% of SANUWAVE Health shares are held by insiders. Comparatively, 10.1% of Biotricity shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Summary

SANUWAVE Health beats Biotricity on 7 of the 11 factors compared between the two stocks.

About SANUWAVE Health

SANUWAVE Health, Inc., a shock wave technology company, researches, develops, and commercializes noninvasive, high-energy, and acoustic shock waves for regenerative medicine and other applications in the United States and internationally. Its shockwaves are used to produce a biological response resulting in the body healing itself through the repair and regeneration of tissue, musculoskeletal, and vascular structures. The company's pulsed acoustic cellular expression systems, including dermaPACE system for treating diabetic foot ulcers and other chronic wounds; orthoPACE system for treating tendinopathies and acute and nonunion fractures; and Profile is used to provide solution for pain management in sports medicine and physical therapy. Its portfolio of wound treatment solutions provides patients with a noninvasive technology that boosts the body's normal healing and tissue regeneration processes. In addition, the company offers UltraMIST, non-contact and non-thermal ultrasound therapy device used to treat diabetic foot ulcers, pressure ulcers, venous leg ulcers, deep tissue pressure injuries, and surgical wounds. SANUWAVE Health, Inc. was founded in 2004 and is headquartered in Eden Prairie, Minnesota.

About Biotricity

Biotricity, Inc., a medical technology company, provides biometric data monitoring solutions in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It offers Bioflux mobile cardiac telemetry solution, an integrated ECG device; and ECG analysis software that analyzes and synthesizes patient ECG monitoring data, as well as software components. The company is based in Redwood City, California.